CAS: 5241-58-7; (S)-2-Amino-3-Phenylpropanamide

该化合物是一种有机化合物,其特点是存在附属于苯丙烯结构的矿物质组,它是氨酸苯丙氨基苯丙胺的衍生物,对蛋白合成至关重要,并参与...

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号7524-50-7 L-苯丙氨酸甲酯盐酸盐 | CAS号5241-56-5 N-苄氧羰基-D-苯丙氨酰胺 | CAS号65864-22-4 L-苯丙氨酰胺盐酸盐 | CAS号3010-05-7 2-(苄基氨基)乙腈 | CAS号63-91-2 L-苯丙氨酸 | CAS号6638-79-5 二甲羟胺盐酸盐 | CAS号543-27-1 氯甲酸异丁酯 | CAS号2577-90-4 (S)-2-氨基-3-苯基丙酸甲酯 | CAS号47091-50-9 Asp-Phe-NH2 | CAS号145232-34-4 3-环己基-l-丙胺酸酰胺 | CAS号85612-59-5 (2R)-3-苯基丙烷-1,2-二胺 | CAS号65864-22-4 L-苯丙氨酰胺盐酸盐 | CAS号64190-70-1 Phe-Met-Arg-Phe,酰胺 | CAS号5534-95-2 五肽胃泌素 | CAS号13171-96-5 Z-Leu-Phe-NH2 | CAS号129095-62-1 [(1R)-2-氨基-1-苄基... | CAS号5513-69-9 N-[(苯基甲氧基)羰基]甘氨... | CAS号1138-80-3 N-苄氧羰基甘氨酸 | CAS号1142-20-7 |N|-苄氧羰基-L-丙氨酸

合成工艺路线路线简述

    L-苯丙氨酸甲酯置于ammonium Hydroxide体系中,用 甲苯 作为反应溶剂,化学反应 16.0H,以79%的收率获得产物l-苯丙氨酰胺
    参考文献:芳香族氨基酸酰胺的合成
    标题:芳香族氨基酸酰胺的合成
    摘要:摘要 芳族氨基酯在甲苯或水中与氢氧化铵水溶液反应,得到中等至高产率的相应酰胺.
    DOI:10.1080/00397919608003803

    海关参考信息

    专利信息


    专利号:US-3846399-A
    优先权日:1969-04-10
    标题:Process for controlled stepwise synthesis of polypeptides
    发明人:HIRSCHMANN R; DENKEWALTER R
    权利人:MERCK & CO INC
    摘要:The invention disclosed herein relates to a novel process for the controlled, stepwise synthesis of polypeptides and proteins. More particularly, it is concerned with a process for the rapid and efficient preparation of polypeptides in which multiple sequential steps are carried out without isolation of intermediate peptides. This process for the controlled stepwise synthesis of polypeptides involves reacting a starting amino acid or peptide (or derivative thereof) with an N-carboxy amino acid anhydride (or derivative thereof) in an aqueous medium under conditions of controlled pH such that the only amino group present in appreciable concentration in reactive form during the course of the reaction is the amino group in the starting amino acid or peptide.

    专利号:US-12018094-B2
    优先权日:2018-04-02
    标 题 :Crystalline dipeptides useful in the synthesis of elamipretide
    发明人:DUNCAN SCOTT M; REDMON MARTIN P
    权利人:STEALTH BIOTHERAPEUTICS INC
    摘要:Disclosed are crystalline forms of L-Lys(Boc)-Phe-NH2 and Boc-D-Arg-DMT. The crystalline forms may be used in the synthesis of elamipretide.

    专利号:US-9126896-B2
    优先权日:2012-06-01
    标题:Synthesis of diamido gellants by using Dane salts of amino acids
    发明人:BINDL MARTIN; HERRMANN ROLAND; KNAUP GUNTER
    权利人:EVONIK INDUSTRIES AG
    摘要:The invention relates to a method for the synthesis of a compound according to formula I comprising the following steps: a) reacting a Dane salt according to formula II and a Dane salt according to formula III with a coupling reagent; b) adding a diamine according to formula IV to the reaction mixture; and c) adding an acid to the reaction mixture to adjust the pH value of the reaction to <7; wherein L represents a C 2 -C 20 alkyl group, a C 6 -C 20 aryl group, or a C 7 -C 20 alkylaryl group; R 1 and R 2 can be identical or different and represent a hydrogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 hydroxyalkyl group, a C 1 -C 4 thioether group, a C 6 -C 20 aryl group, a C 7 -C 20 alkylaryl group, a C 7 -C 20 alkylhydroxyaryl group, a C 4 -C 20 alkylheteroaryl group with 1 to 4 heteroatoms; or a C 1 -C 4 alkylcarboxylic moiety, which may be an acid, an amide, or which may be esterified with a C 1 -C 6 alkyl group or a C 7 -C 20 alkylaryl group; R 3 represents a C 1 -C 4 alkyl group; R 4 represents a hydrogen atom, or a C 1 -C 4 alkyl group; R 5 represents a C 1 -C 4 alkyl group; and X represents an alkali metal.

    专利号:EP-1960423-B1
    优先权日:2004-12-30
    标 题:Synthesis of peptide t-20 using peptide intermediate fragments
    发明人:HAN YEUN-KWEI; JOHNSTON DAVID A; KHATRI HIRALAL N
    权利人:HOFFMANN LA ROCHE
    摘要:Methods for the solid phase synthesis of T-20 peptides and peptide intermediates, in particular methods involving synthesizing T-20 peptide intermediates at low loading factors to produce products having excellent purity and yield.

    专利号:US-9475757-B2
    优先权日:2013-05-03
    标 题 :Synthesis of anti-Parkinson agent
    发明人:MUTHUKRISHNAN MURUGAN; MUJAHID MOHAMMAD
    权利人:COUNCIL SCIENT IND RES
    摘要:The present invention relates to an improved process for synthesis of anti-Parkinson compound of formula (I) from commercially available (R)-benzyl glycidyl ether, wherein the compound obtained has enantiopurity greater than >98%. Formula (I) wherein R 1 and R 2 are each independently selected from hydrogen or halogen.

    专利号:US-4769445-A
    优先权日:1985-03-04
    标 题:Process for the solid phase synthesis of peptides which contain sulfated tyrosine
    发明人:COMSTOCK JEANNE; ROSAMOND JAMES D
    权利人:PENNWALT CORP
    摘要:Peptides and Peptide amides such as cholecystokinin (CCK-8) are synthesized in improved yields and purity by a solid phase process. The requisite protected peptide is elaborated and sulfated on a solid support, deprotected, and cleaved from the solid support to give the total synthesis of CCK-8 on a solid support. Thereafter, the peptide is purified in a single step by ion exchange chromatography to provide analytically pure CCK-8.
    成都创科诚生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ckcbiotech.com
    电话: 028-028-0000000 13008177686👤
    📞成都创科诚生物科技有限公司 ⚠️参考联系方式

    销售电话:028-028-0000000 13008177686
    邮箱:sales@ckcbiotech.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:武侯立交桥东祥云路1169号红帆蓝调1-12-16
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: A V Chetkauskate, Et Al. [参考文献]: Zh Evol Biokhim Fiziol. 1988 Jul-Aug;24(4):465-70.
    [参考文献]: D Meredith, Et Al. Modified Amino Acids And Peptides As Substrates For The Intestinal Peptide Transporter Pept1. Eur J Biochem. 2000 Jun;267(12):3723-8.
    [参考文献]: D Prschke, Et Al. Stability Decrease Of Rna Double Helices By Phenylalanine-, Tyrosine- And Tryptophane-Amides. Analysis In Terms Of Site Binding And Relation To Melting Proteins. Nucleic Acids Res. 1982 Oct 11;10(19):6163-76.
    [参考文献]: E Vianini, Et Al. In Vitro Selection Of Dna Aptamers That Bind L-Tyrosinamide. Bioorg Med Chem. 2001 Oct;9(10):2543-8.
    [参考文献]: J F Rehfeld, Et Al. Accurate Measurement Of Cholecystokinin In Plasma. Clin Chem. 1998 May;44(5):991-1001.

    合成参考文献


    摘要:Asano, Y., Science of Synthesis: Biocatalysis in Organic Synthesis, (2015) 1, 267.
    参考文献:10.1007/bf03190569
    摘要:Webber C, Stokes CA, Persiani S, Makovec F, McBurney A, Kapil RP, John BA, D’Amato M, Chasseaud LF. Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the dog. European Journal of Drug Metabolism and Pharmacokinetics. 2004 Mar;29(1):15–23. doi: 10.1007/bf03190569.
    参考文献:10.1186/1471-2210-6-14|10.1186/1471-2210-6-9
    摘要:Banerjee S, Evanson J, Harris E, Lowe SL, Speth RC, Thomasson KA, Porter JE. Erratum to: Identification of specific calcitonin-like receptor residues important for calcitonin gene-related peptide high affinity binding. BMC Pharmacology. 2006 Dec 06;6(1):14. doi: 10.1186/1471-2210-6-14.
    参考文献:10.1007/s10540-006-9008-x
    摘要:Harikumar KG, Pinon DI, Miller LJ. Fluorescence characteristics of hydrophobic partial agonist probes of the cholecystokinin receptor. Biosci Rep. 2006 Apr;26(2):89–100. doi: 10.1007/s10540-006-9008-x.
    参考文献:10.1021/jo011041w
    摘要:Han Y, Giragossian C, Mierke DF, Chorev M. Ni-to-Ni+ 3-Ethylene-Bridged Partially Modified Retro-Inverso Tetrapeptide β-Turn Mimetic: Design, Synthesis, and Structural Characterization. J. Org. Chem. 2002 Jun 19;67(15):5085–97. doi: 10.1021/jo011041w.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知